"Stroke Drug Development: Improving Clinical Trial Design and Endpoint Selection" 
 

STAIR II Sponsors
Abbott Laboratories

Apollo BioPharmaceutics

AstraZeneca

Aventis

Pharmaceuticals

Bayer AG

Boehringer Ingelheim

Pharma, Inc.

Bristol-Myers Squibb Cato Research, Ltd.

ClinTrials Research Inc.

Creative BioMolecules, Inc.

Daiichi Pharmaceutical Co.,

Ltd. D-Pharm Ltd.. Eisai Corp.,

Ltd. Eli Lilly & Co.

Elan Pharmaceuticals

Hoffmann-LaRoche Inc.

Incara Pharmaceuticals

Inotek, Inc.

Janssen Pharmaceutica

Knoll Pharmaceuticals

Layton BioScience, Inc.

Merck & Company

Millennium Pharmaceuticals, Inc.

Mitsubishi Chemical.

Neuron Therapeutics

Parexel International

Parke-Davis Pharmaceuticals

Pfizer Central Research

Schering AG/Berlex Labs

Skye Pharmatech

Suntory Pharmaceutical, Inc.

t.Breeders, Inc.

oray Industries, Inc.

VIRTUEALITY

Consulting Warren-Hewitt Associates Ltd.

Yamanouchi U.S.A. Inc.